LncRNA LOXL1‐AS1/miR‐let‐7a‐5p/ EGFR ‐related pathway regulates the doxorubicin resistance of prostate cancer DU‐145 cells

lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis

(2018) Li Qi et al.   BIOMEDICINE & PHARMACOTHERAPY

Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway

(2018) Bin Zhao et al.   Cancer Biomarkers

Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling

(2018) Yubo Tang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1

(2018) Bo Long et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation

(2018) Li Ma et al.   BIOMEDICINE & PHARMACOTHERAPY

LOX/LOXL in pulmonary fibrosis: potential therapeutic targets

(2018) Lijun Chen et al.   JOURNAL OF DRUG TARGETING

Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195

(2017) Dingli Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR

(2017) Wei Wei et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling

(2017) Yuanyuan Lu et al.   NATURE MEDICINE

An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation

(2017) Yingyi Zhang et al.   PLoS One

Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution

(2016) Benjamin Le Calvé et al.   Oncotarget

Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer

(2016) Maria Nilsson et al.   Scientific Reports

Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B

(2015) Seo-Young Kwak et al.   FEBS Journal

Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within theLOXL1locus

(2015) Michael A. Hauser et al.   HUMAN MOLECULAR GENETICS

MicroRNA-Let-7a regulates the function of microglia in inflammation

(2015) Kyoung Joo Cho et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives

(2015) Dong-Liang Cheng et al.   TUMOR BIOLOGY

Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation

(2015) Lakshmi Reddy Bollu et al.   Oncotarget

Simultaneous Inhibition of EGFR/VEGFR and Cyclooxygenase-2 Targets Stemness-Related Pathways in Colorectal Cancer Cells

(2015) Araceli Valverde et al.   PLoS One

Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel

(2014) Adriana Amaro et al.   CANCER AND METASTASIS REVIEWS

Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway

(2014) Firdous Ahmad Bhat et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

EGFR signaling and autophagy dependence for growth, survival, and therapy resistance

(2013) Barry Jutten et al.   CELL CYCLE

Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases

(2012) E. David Crawford et al.   JOURNAL OF UROLOGY

Prostate cancer epidemiology in the United States

(2012) Otis W. Brawley   WORLD JOURNAL OF UROLOGY

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

(2011) Jack Cuzick et al.   LANCET ONCOLOGY

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

(2010) A. Das et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA